Ramirez Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Ramirez Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-254	Closed	-$3.56K	–	371
2025 Q4	$3.56K	Sell	254 -246	-49%	-$3.45K	﹤0.01%	346
2025 Q3	$6.99K	Hold	500	–	–	﹤0.01%	341
2025 Q2	$7.51K	Sell	500 -10	-2%	-$143	﹤0.01%	330
2025 Q1	$6.73K	Sell	510 -515	-50%	-$7.11K	﹤0.01%	365
2024 Q4	$16.2K	Sell	1,025 -5	-0.5%	-$75	﹤0.01%	340
2024 Q3	$16.3K	Hold	1,030	–	–	﹤0.01%	347
2024 Q2	$15.7K	Sell	1,030 -215	-17%	-$3.08K	﹤0.01%	350
2024 Q1	$18.2K	Sell	1,245 -113,825	-99%	-$1.66M	﹤0.01%	344
2023 Q4	$1.6M	Sell	115,070 -10,565	-8%	-$141K	0.32%	96
2023 Q3	$1.68M	Buy	+125,635	New	+$1.7M	0.36%	91

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Ramirez Asset Management's RDY Position: Q1 2026 in Review

Ramirez Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 254 shares — an estimated $3.56K sold.

Ramirez Asset Management first reported a position in RDY in Q3 2023 and held it in 10 quarters. The position peaked at $1.68M in Q3 2023. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Ramirez Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
Ramirez Asset Management sold 254 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $3.56K.
Ramirez Asset Management first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 10 quarters.
Ramirez Asset Management's Dr. Reddy's Laboratories position peaked at $1.68M in Q3 2023.
249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Ramirez Asset Management's 13F filing for Q1 2026, filed 12 May 2026.